NCDActive
Non-Implantable Pelvic Floor Electrical Stimulator
NCD231
Effective: June 19, 2006
Updated: December 31, 2025
Policy Summary
Non-implantable pelvic floor electrical stimulation is covered for treatment of stress or urge urinary incontinence in cognitively intact patients only after a documented failed trial of pelvic muscle exercise training (no clinically significant improvement after 4 weeks of an ordered PME plan). Documentation must include the incontinence diagnosis, the ordered PME plan and its 4-week completion with failure outcome, and evidence the patient is cognitively intact. The policy applies to non-implantable stimulators; implantable devices are outside this policy's scope.
Coverage Criteria Preview
Key requirements from the full policy
"Non-implantable pelvic floor electrical stimulation is covered for treatment of stress urinary incontinence or urge urinary incontinence in patients who are cognitively intact and who have failed a..."
Sign up to see full coverage criteria, indications, and limitations.